DUPONT CAPITAL MANAGEMENT CORP - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 200 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
DUPONT CAPITAL MANAGEMENT CORP ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$299,000
+4.5%
13,258
-8.1%
0.01%
+20.0%
Q4 2021$286,000
-28.0%
14,431
-28.5%
0.01%
-16.7%
Q3 2021$397,000
-45.8%
20,185
-39.4%
0.01%
-29.4%
Q2 2021$733,000
-7.4%
33,2960.0%0.02%
-10.5%
Q1 2021$792,000
-24.6%
33,296
-17.0%
0.02%
-13.6%
Q4 2020$1,050,000
+39.8%
40,125
-6.9%
0.02%
+29.4%
Q3 2020$751,000
+30.6%
43,120
+26.2%
0.02%
+30.8%
Q2 2020$575,000
+29.8%
34,167
-8.2%
0.01%
+18.2%
Q1 2020$443,000
-60.3%
37,218
-59.6%
0.01%
-56.0%
Q4 2019$1,115,000
-5.9%
92,127
+9.9%
0.02%
-7.4%
Q3 2019$1,185,000
+14.5%
83,855
-9.7%
0.03%
+12.5%
Q2 2019$1,035,000
-5.0%
92,8450.0%0.02%
-4.0%
Q1 2019$1,090,000
-12.1%
92,8450.0%0.02%
-16.7%
Q4 2018$1,240,000
-4.8%
92,8450.0%0.03%
+3.4%
Q3 2018$1,302,000
-10.8%
92,8450.0%0.03%
-17.1%
Q2 2018$1,460,000
-4.4%
92,8450.0%0.04%
-5.4%
Q1 2018$1,527,000
-28.1%
92,845
-21.0%
0.04%
-24.5%
Q4 2017$2,123,000
-6.4%
117,5390.0%0.05%
-3.9%
Q3 2017$2,269,000
+63.6%
117,5390.0%0.05%
+64.5%
Q2 2017$1,387,000117,5390.03%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 6,911,376$155,644,0006.95%
Parallel Advisors, LLC 1,944,319$47,014,0001.86%
TANAKA CAPITAL MANAGEMENT INC 39,289$885,0001.79%
S&T BANK/PA 508,546$11,452,0001.73%
Bridge City Capital, LLC 83,967$1,891,0000.88%
Birchview Capital, LP 50,000$1,126,0000.81%
Quantedge Capital Pte Ltd 113,012$2,545,0000.75%
FAS Wealth Partners, Inc. 289,625$6,522,0000.61%
AJ WEALTH STRATEGIES, LLC 396,029$8,919,0000.44%
TRUSTCORE FINANCIAL SERVICES, LLC 208,806$4,702,0000.41%
View complete list of CORCEPT THERAPEUTICS INC shareholders